Most Expensive Drugs in the world:

The most expensive drug in the world is a tie between two medications: Zolgensma and Luxturna.

Zolgensma: is a gene therapy for the treatment of spinal muscular atrophy (SMA), a rare and often fatal genetic disorder that causes muscle weakness and difficulty with movement. It is administered as a one-time injection and has been shown to significantly improve outcomes in children with SMA. The price of Zolgensma is a staggering $2.1 million per treatment, making it the most expensive drug in the world.

Luxturna: is also a gene therapy, used to treat inherited retinal dystrophy, a rare genetic condition that causes vision loss. It is administered as a series of injections into the eye and has been shown to significantly improve vision in patients with the condition. The price of Luxturna is also $850,000 per treatment, making it tied with Zolgensma as the most expensive drug in the world.

Both Zolgensma and Luxturna are pioneering treatments that have the potential to greatly improve the lives of patients with rare and often debilitating conditions. However, their high cost has raised concerns about access to these therapies for patients who may benefit from them. Some have called for more transparency in the pricing of these drugs, as well as for policies to ensure that they are affordable for those who need them.

It's important to note that the high cost of these drugs is due in part to the high cost of developing and producing them. Gene therapies like Zolgensma and Luxturna are highly complex and involve cutting-edge technologies, and the companies that develop them incur significant research and development costs. However, this does not fully justify the high prices of these drugs, and it is important for policymakers, patient advocates, and the pharmaceutical industry to work together to find ways to make these life-changing therapies more accessible to those who need them.